Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 70.30
-0.70 (-0.99%)
Sep 26, 2025, 4:08 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 20.71 billion as of September 26, 2025. Its market cap has increased by 113.92% in one year.
Market Cap
20.71B
Enterprise Value
18.60B
Revenue
955.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
70.30
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has increased from 18.43B to 20.71B, an increase of 12.39%. That is a compound annual growth rate of 2.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 20.71B | 143.19% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | 18.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 282.45B |
| JD Health International | 216.90B |
| Hansoh Pharmaceutical Group Company | 211.53B |
| Innovent Biologics | 162.80B |
| WuXi Biologics | 162.39B |
| Sino Biopharmaceutical | 143.08B |
| Akeso | 122.79B |
| Sichuan Kelun-Biotech Biopharmaceutical | 116.17B |